# Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning

> **NCT01161277** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 54 (actual)

## Conditions studied

- Psychosis
- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Haloperidol
- **DRUG:** Placebo sugar pill

## Key facts

- **NCT ID:** NCT01161277
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01161277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01161277, "Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01161277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*